Levels of VEGF or FGF-2, though unchanged between placental insufficiency and control, correlated to the elevated concentrations of PAI-1 in control pregnancies (Figure 2(a) (i) and (ii)). The gene discussed is VEGFA; the disease is placental insufficiency.